Voya Investment Management LLC Has $29.43 Million Stake in MetLife, Inc. $MET

Key Points

• Voya Investment Management LLC increased its stake in MetLife, Inc. by 3.6% during the first quarter, now owning approximately 0.05% of the company worth $29.4 million.
• MetLife's latest earnings report showed an EPS of $2.02, missing analysts' expectations of $2.32, and a revenue of $17.34 billion, below the projected $18.58 billion.
• The company announced a quarterly dividend of $0.5675 per share, yielding 2.8%, contributing to its dividend payout ratio of 38.47%.

Voya Investment Management LLC increased its holdings in shares of MetLife, Inc. (NYSE:MET - Free Report) by 3.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 366,556 shares of the financial services provider's stock after purchasing an additional 12,877 shares during the period. Voya Investment Management LLC owned approximately 0.05% of MetLife worth $29,431,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of MET. First Horizon Advisors Inc. lifted its stake in MetLife by 4.8% in the 1st quarter. First Horizon Advisors Inc. now owns 422,684 shares of the financial services provider's stock valued at $33,937,000 after acquiring an additional 19,192 shares in the last quarter. Ritholtz Wealth Management lifted its stake in MetLife by 52.1% in the 1st quarter. Ritholtz Wealth Management now owns 9,355 shares of the financial services provider's stock valued at $751,000 after acquiring an additional 3,204 shares in the last quarter. Pinnacle Financial Partners Inc bought a new stake in MetLife in the 1st quarter valued at approximately $255,000. Mirae Asset Global Investments Co. Ltd. lifted its stake in MetLife by 20.7% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 60,785 shares of the financial services provider's stock valued at $4,735,000 after acquiring an additional 10,414 shares in the last quarter. Finally, Heartland Bank & Trust Co bought a new stake in MetLife in the 1st quarter valued at approximately $516,000. Institutional investors own 94.99% of the company's stock.

MetLife Stock Performance

Shares of MET stock traded down $0.36 during trading on Monday, reaching $80.46. 3,083,802 shares of the company's stock were exchanged, compared to its average volume of 2,625,359. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.57. The stock has a market capitalization of $53.51 billion, a PE ratio of 13.64, a PEG ratio of 0.73 and a beta of 0.87. MetLife, Inc. has a twelve month low of $65.21 and a twelve month high of $89.05. The firm's fifty day moving average price is $78.27 and its 200-day moving average price is $78.21.

MetLife (NYSE:MET - Get Free Report) last posted its earnings results on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share for the quarter, missing analysts' consensus estimates of $2.32 by ($0.30). The business had revenue of $17.34 billion for the quarter, compared to analyst estimates of $18.58 billion. MetLife had a return on equity of 19.88% and a net margin of 5.83%.The firm's revenue was down 2.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.28 earnings per share. As a group, sell-side analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 5th were issued a $0.5675 dividend. This represents a $2.27 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend was Tuesday, August 5th. MetLife's dividend payout ratio is currently 38.47%.

Wall Street Analysts Forecast Growth

MET has been the topic of a number of analyst reports. Keefe, Bruyette & Woods dropped their price objective on MetLife from $94.00 to $92.00 and set an "outperform" rating on the stock in a research note on Monday, August 11th. Barclays upped their price objective on MetLife from $88.00 to $94.00 and gave the stock an "overweight" rating in a research note on Monday, July 7th. Morgan Stanley dropped their price objective on MetLife from $98.00 to $94.00 and set an "overweight" rating on the stock in a research note on Monday, August 18th. Cowen reiterated a "buy" rating on shares of MetLife in a research note on Friday, August 22nd. Finally, JPMorgan Chase & Co. upped their price objective on MetLife from $86.00 to $95.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 8th. Eleven equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $95.55.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.